Caplin Point Laboratories Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Caplin Point Laboratories Limited with three other
companies in this sector in INDIA :
Suven Life Sciences Limited
(2019
sales of 6.64 billion Indian Rupees [US$88.38 million]
of which 93%
was Manufacturing),
Fresenius Kabi Oncology Limited
(6.60 billion Indian Rupees [US$87.85 million]
of which 70%
was Formulation), and
Neuland Laboratories Limited
(6.67 billion Indian Rupees [US$88.82 million]
of which 100%
was Bulk Drugs).

Sales Analysis.
Caplin Point Laboratories Limited reported sales of 6.49 billion Indian Rupees (US$86.41 million)
for the
fiscal
year ending
March of 2019.
This
represents
an
increase of 20.2%
versus 2018, when the company's sales were 5.40 billion Indian Rupees .
Sales at Caplin Point Laboratories Limited have increased during each of the previous five years
(and since 2014, sales have increased a total of 275%).